Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

SDCCAG1 Inhibitors

SDCCAG1 Inhibitors represent a category of chemical compounds designed to target and modulate the function of the SDCCAG1 protein. SDCCAG1, also known as serologically defined colon cancer antigen 1, is a protein involved in various cellular processes, including cell signaling, intracellular trafficking, and potentially immune response regulation. Inhibitors specific to SDCCAG1 are engineered to interfere with its activity, impacting the functions and pathways associated with this protein within the cell.

The mechanism of action of SDCCAG1 inhibitors typically involves binding to specific sites or domains within the SDCCAG1 protein. Through this interaction, these inhibitors may disrupt the protein's role in cellular signaling cascades, potentially affecting signaling pathways or intracellular trafficking processes. Researchers utilize SDCCAG1 inhibitors as essential tools to investigate the diverse functions of SDCCAG1 in cellular biology, shedding light on its impact on cellular processes and potentially revealing insights into its contributions to cellular homeostasis and immune responses. By probing the function of SDCCAG1 through inhibition, scientists aim to uncover the underlying molecular mechanisms that govern a wide range of cellular activities.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MLN 8054

869363-13-3sc-484828
5 mg
$398.00
(0)

MLN8054 is an inhibitor of Aurora A kinase, disrupting cell cycle progression, indirectly impacting SDCCAG1 regulation.

AZD1152-HQPA

722544-51-6sc-265334
10 mg
$375.00
(0)

AZD1152 is a selective inhibitor of Aurora B kinase, affecting mitotic processes and SDCCAG1 regulation indirectly.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

ZM447439 inhibits both Aurora A and B kinases, disrupting cell division and impacting SDCCAG1 expression indirectly.

Reversine

656820-32-5sc-203236
5 mg
$221.00
13
(1)

Reversine is an ATP-competitive inhibitor of Aurora A and B kinases, disrupting mitotic processes and SDCCAG1 indirectly.

ON-01910

1225497-78-8sc-364556
sc-364556A
5 mg
10 mg
$300.00
$700.00
(0)

ON-01910 is a multi-kinase inhibitor, including PLK1, disrupting mitosis and cell cycle events, indirectly impacting SDCCAG1.